If you are asking what insurance companies cover ketamine, here is the short version: most major insurers, including Aetna, Blue Cross Blue Shield, Cigna, United Healthcare, and Medicare, cover FDA-approved Spravato (esketamine) when treatment-resistant depression criteria are met. Almost none of them routinely cover IV or IM ketamine, because those formats are used off-label. This 2026 checklist breaks down each major insurer, explains the Spravato versus IV coverage split, and gives you a clear process to confirm what your own plan will pay.
| What we know
1. Most major insurers cover FDA-approved Spravato (esketamine) for treatment-resistant depression when clinical criteria and prior authorization requirements are met. 2. IV and IM ketamine are off-label for mental health and are generally not covered by any major insurer, though out-of-network reimbursement is sometimes possible. 3. Coverage depends on your specific plan, your diagnosis, and your state. This checklist is a starting point, not a substitute for verifying your own benefits. |
Note for the client: the insurer coverage details below are general and change frequently. Please have a billing or compliance team member verify the insurer-specific information before publishing.
Quick-Reference Checklist: Major Insurers and Ketamine Coverage
Here is the 2026 landscape at a glance. Coverage is plan-specific, so treat this as a guide to what is typical, not a guarantee of your individual benefits.
| Insurance Company | Spravato (Esketamine) | IV / IM Ketamine |
| Aetna | Typically covered, prior auth required | Not typically covered |
| Blue Cross Blue Shield | Typically covered, prior auth required | Not typically covered |
| Cigna | Typically covered, prior auth required | Not typically covered |
| United Healthcare | Typically covered, prior auth required | Not typically covered |
| Humana | Often covered, prior auth required | Not typically covered |
| Medicare | Often covered when criteria met | Not typically covered |
| Medicaid | Varies by state | Not typically covered |
The takeaway is consistent across the board: Spravato is widely covered when treatment-resistant depression criteria are met, and IV or IM ketamine generally is not. Below, each insurer is covered in a little more detail.
Why the Spravato vs IV Ketamine Coverage Split Exists
Before going insurer by insurer, it helps to understand the single rule behind almost every coverage decision: FDA approval status. Spravato (esketamine) is FDA-approved for treatment-resistant depression. IV and IM ketamine are FDA-approved only as anesthetics, so using them for depression is off-label. Insurers tie coverage to FDA-approved uses. That is why esketamine is covered and the same molecule delivered by IV usually is not. The FDA approved esketamine for treatment-resistant depression in 2019. Keep this rule in mind as you read the insurer details below: when an insurer covers ketamine, it almost always means Spravato.
Major Insurers and Ketamine Coverage in Detail
Aetna
Aetna typically covers Spravato for treatment-resistant depression when prior authorization is approved. Approval generally requires documentation of a treatment-resistant depression diagnosis and failure of two or more antidepressants. IV and IM ketamine are not typically covered as off-label treatments.
Blue Cross Blue Shield (BCBS)
BCBS plans typically cover Spravato with prior authorization. Because BCBS operates as a federation of regional plans, exact requirements and co-pays vary by state and specific policy. IV ketamine is generally not covered. Verifying with your specific BCBS plan is especially important.
Cigna
Cigna typically covers Spravato for treatment-resistant depression with prior authorization, following the standard criteria of documented diagnosis and prior antidepressant trials. IV and IM ketamine are not typically covered.
United Healthcare
United Healthcare typically covers Spravato when prior authorization criteria are met. As with other major insurers, IV ketamine for mental health is generally treated as off-label and not covered. United Healthcare is one of the insurers Village TMS works with for Spravato coverage.
Humana
Humana often covers Spravato for treatment-resistant depression, including through its Medicare Advantage plans, with prior authorization. IV and IM ketamine are not typically covered.
Medicare and Medicaid Coverage for Ketamine
Government insurance follows the same FDA-approval logic, with some additional variation.
Medicare often covers Spravato for treatment-resistant depression when clinical criteria are met, typically under Part B or through a Medicare Advantage plan, since Spravato is administered in a clinical setting. IV ketamine for depression is generally not covered by Medicare.
Medicaid coverage for Spravato varies significantly by state, because Medicaid is administered at the state level. Some state Medicaid programs cover esketamine for treatment-resistant depression; others do not. IV and IM ketamine are generally not covered by Medicaid. If you have Medicaid, checking your specific state program is essential.
How to Confirm What Your Specific Plan Covers
This checklist tells you what is typical. Only your insurer can tell you what your plan actually covers. Here is how to get a definitive answer:
- Call the member services number on your insurance card.
- Ask specifically about esketamine (Spravato) coverage for treatment-resistant depression. Use the word esketamine, as it is the term insurers recognize.
- Ask what prior authorization requires, including which documents your provider must submit and how long approval takes.
- Ask separately about IV ketamine and your out-of-network mental health benefits.
- Request co-pay, co-insurance, and deductible details so you know your actual out-of-pocket cost.
Many clinics will run this verification for you. For a fuller explanation of how coverage works and why it varies, see our guide on whether insurance covers ketamine therapy.
What to Do If Your Insurer Doesn’t Cover Ketamine
If your plan does not cover the treatment you need, you still have routes forward:
- Appeal a Spravato denial. Your provider can submit additional documentation of medical necessity. Appeals succeed often enough to be worth pursuing.
- Submit a superbill for IV ketamine. Even without in-network coverage, you may recover part of the cost through out-of-network reimbursement.
- Use HSA or FSA funds. Both typically cover ketamine therapy as an eligible medical expense, letting you pay with pre-tax dollars.
- Ask about payment plans and medical financing. Most clinics offer installment options or work with financing programs such as CareCredit.
- Consider lower-cost formats. IM ketamine costs less per session than IV. Our guide to ketamine therapy cost without insurance covers self-pay options in detail.
Let Village TMS Check Your Insurance for You
Rather than spending hours on hold with your insurer, let Village TMS do the verification. Our Manhattan team confirms your specific benefits, handles prior authorization for Spravato, and gives you a clear cost picture before treatment begins. We offer IV, IM, and Spravato, so we can match treatment to your coverage and your needs. Call 646-817-2835 or contact us to book a free consultation.
